ArticleCancer2017

Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.

Amer M Zeidan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.